Concepedia

Tarik A. Khan

TA

15

Publications

1.1K

Citations

13

H-Index

2012

Active since

Affiliations

Roche (Switzerland)(Current)

ETH Zurich

The University of Texas at Austin

University of Basel

Ludwig-Maximilians-Universität München

Tarik A. Khan is an author at Roche (Switzerland) specializing in engineering, medicine, and bioanalysis.

ORCID

Top concepts

Publications per year

2012–2023

15

Publications

15

Trastuzumab emtansine (T-DM1) renders HER2 <sup>+</sup> breast cancer highly susceptible to CTLA-4/PD-1 blockade

Philipp Müller, Matthias Kreuzaler, Tarik A. Khan et al. · Science Translational Medicine · 2015 · 328 citations

, , +17

Concentrated Dispersions of Equilibrium Protein Nanoclusters That Reversibly Dissociate into Active Monomers

Keith P. Johnston, Jennifer A. Maynard, Thomas M. Truskett et al. · ACS Nano · 2012 · 122 citations

, , +23

Accurate and predictive antibody repertoire profiling by molecular amplification fingerprinting

Tarik A. Khan, Simon Friedensohn, Arthur R. Gorter de Vries et al. · Science Advances · 2016 · 116 citations · Full text

In Vivo Whole Animal Fluorescence Imaging of a Microparticle-Based Oral Vaccine Containing (CuInSe<sub><i>x</i></sub>S<sub>2–<i>x</i></sub>)/ZnS Core/Shell Quantum Dots

Matthew G. Panthani, Tarik A. Khan, Dariya K. Reid et al. · Nano Letters · 2013 · 100 citations · Full text

Quantitative assessment of the robustness of next-generation sequencing of antibody variable gene repertoires from immunized mice

Victor Greiff, Ulrike Menzel, Ulrike Haessler et al. · BMC Immunology · 2014 · 71 citations · Full text

Rows per page

1–5 of 15